Obesity drug supply-demand imbalance is working in Novo Nordisk's favor: Mizuho's Jared Holz voir sur Youtube
Investors are jumping back into the market, according to the latest Investopedia investor survey voir sur Youtube
Lending issues are 'slow but there' and starting to 'ripen', says Raging Capital's Bill Martin voir sur Youtube
It was 'completely irrational' for the market to price in a March rate cut, says Michael Contopoulos voir sur Youtube